Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
Philippe Généreux1, MD; Roxana Mehran1, MD; Tullio Palmerini1, MD; Adriano Caixeta1, MD, PhD; Ajay J. Kirtane1, MD, SM; Alexandra J. Lansky1, MD; Bruce R. Brodie2, MD; Bernhard Witzenbichler3, MD; Martin Mockel3, MD; Giulio Guagliumi4, MD; Jan Z. Peruga5, MD; Dariusz Dudek6, MD; Martin P Fahy1, MSc; George Dangas1, MD, PhD; Gregg W. Stone1*, MD; for the HORIZONS-AMI Trial Investigators
1. Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA; 2. LeBauer Cardiovascular Research Foundation and Moses Cone Hospital, Greensboro, NC, USA; 3. Charité-Universitätsmediz in Berlin, Cam
Aims: We sought to determine whether a transradial (TR) approach compared with a transfemoral (TF) approach was associated with improved clinical outcomes in patients with ST-segment elev
